Phase 2/3 Oxabact Study
NCT01037231
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hyperoxaluria
Interventions
BIOLOGICAL:
Oxalobacter formigenes
DRUG:
Placebo
Sponsor
OxThera